about
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levelsCerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease.Insulin sensitivity, β-cell function, and incretin effect in individuals with elevated 1-hour postload plasma glucose levels.Comment on: Straznicky et al. neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjects. Diabetes 2012;61:2506-2516.Retinal neurodegeneration in patients with type 1 diabetes mellitus: the role of glycemic variability.Impact of glycemic variability on cardiovascular outcomes beyond glycated hemoglobin. Evidence and clinical perspectives.Glucose variability: An emerging target for the treatment of diabetes mellitus.Early microvascular retinal changes in optical coherence tomography angiography in patients with type 1 diabetes mellitus.The social burden of hypoglycemia in the elderly.The need for identifying standardized indices for measuring glucose variability.Comment on: Kromhout et al. n-3 fatty acids, ventricular arrhythmia-related events, and fatal myocardial infarction in postmyocardial infarction patients with diabetes. Diabetes Care 2011;34:2515-2520.Polymorphisms of the insulin receptor substrate-2 in patients with type 2 diabetes.Metabolic effects of IGF-I in diabetic rats.Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients.Acute caloric restriction improves glomerular filtration rate in patients with morbid obesity and type 2 diabetes.The Arg972 variant in insulin receptor substrate-1 is associated with an increased risk of secondary failure to sulfonylurea in patients with type 2 diabetes.The -866A/A genotype in the promoter of the human uncoupling protein 2 gene is associated with insulin resistance and increased risk of type 2 diabetes.Insulin clearance is associated with carotid artery intima-media thickness.Preliminary evidence that obese patients with obstructive sleep apnea/hypopnea syndrome are refractory to the acute beneficial metabolic effects of a very low calorie diet.Insulin secretion in metabolically obese, but normal weight, and in metabolically healthy but obese individuals.The ideal blood pressure target to prevent cardiovascular disease in type 2 diabetes: a neutral viewpoint.Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in a Real-Life Setting: A 24-Month, Multicenter, Non-interventional, Retrospective Study.Single Retinal Layer Evaluation in Patients with Type 1 Diabetes with No or Early Signs of Diabetic Retinopathy: The First Hint of Neurovascular Crosstalk Damage between Neurons and Capillaries?Deep capillary plexus impairment in patients with type 1 diabetes mellitus with no signs of diabetic retinopathy revealed using optical coherence tomography angiography.Acute hyperglycemia reduces cerebrovascular reactivity: the role of glycemic variability.Effect of the GSTM1 gene deletion on glycemic variability, sympatho-vagal balance and arterial stiffness in patients with metabolic syndrome, but without diabetes.Increased left ventricular mass in normotensive diabetic patients with autonomic neuropathy.Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.Differences in insulin clearance between metabolically healthy and unhealthy obese subjects.Very-low-calorie diet: a quick therapeutic tool to improve β cell function in morbidly obese patients with type 2 diabetes.Metabolic syndrome in subjects at high risk for type 2 diabetes: the genetic, physiopathology and evolution of type 2 diabetes (GENFIEV) study.Carotid artery intima-media thickness is associated with insulin-mediated glucose disposal in nondiabetic normotensive offspring of type 2 diabetic patients.Effects of insulin on cholesterol synthesis in type II diabetes patients.The effects of insulin on plasma mevalonate concentrations in man.QTc and autonomic neuropathy in diabetes: effects of acute hyperglycaemia and n-3 PUFA.Correspondence between the International Diabetes Federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic Caucasians: the GISIR database.C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance.Cardiovascular Autonomic Neuropathy and Glucose Variability in Patients With Type 1 Diabetes: Is There an Association?Association between Early Neuroretinal Dysfunction and Peripheral Motor Unit Loss in Patients with Type 1 Diabetes MellitusCardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management
P50
Q35032441-199A2B29-E6C4-45C1-85B4-FA6272DBD226Q35082425-13368248-411B-42A4-A20B-F7D257A3538DQ35841265-EFD9AB3D-455D-4937-BD22-42F2D3E7815AQ36477329-4AA3B4B3-69A2-441B-9BA1-0A796B6812E6Q37742818-0E79873C-EB14-4083-A111-AD24713BBB2CQ38016729-EC38AF22-7829-484B-9CB3-39109C4C6E57Q38152894-CE3D0B97-F24B-489C-B98E-B0553C13CFD1Q38955628-06B4D1C0-FFA9-4061-AA4C-866580BB7AC8Q41462740-88D958C4-58FA-4277-96E3-50E3D7D73346Q42555071-52392DA4-D2ED-4C7E-B2B6-9CC5EED4412CQ43179563-3E034BC9-87EB-4B1A-BD7D-EDAB1F385D1AQ44273306-147FF271-C08E-4926-8DAD-09B679853FC1Q44312517-661B2AE6-700F-4321-8D4B-1687C1F0D8D6Q44438491-E6D597C2-79CD-43AB-BB60-00C36E4AC636Q44497574-2C5F2F46-5402-4C45-BA59-FA14DFD21DB8Q44909546-8EED654A-6D90-45FB-97DB-06CCE9A09503Q44953952-EEE419DB-214E-4F4E-9423-D6DEAC34E9F5Q45897686-64995E4E-9F29-4009-9DA5-1B33E50F8880Q46469310-5BD8D223-F34E-4B84-A1C0-26620E56A222Q46542315-11632466-9261-44CF-B72F-68E2AB962511Q46866020-0DBF2C6A-3983-4C12-B505-524C960BF133Q47261662-1A29CB47-0F24-4400-87AB-9C133784AFC9Q47894177-8C4103AC-7C0C-499D-9793-A56336AF9F3FQ48099158-C4E428B3-E139-4EE4-8613-F56CC45C32B7Q48751045-EBEDDABD-0DAE-4C88-B088-F676F418F66CQ49923356-4BDD39ED-1636-47D5-BF7B-76755926627AQ51058408-2C038B04-4AA8-44E8-8312-3D2D207AC957Q51238829-F9D8753D-405A-44CB-AB1D-C4C6B3F14E5AQ51335063-7A5C1112-6388-46C0-B9E5-59EEF50A71D9Q51361351-0966963D-B9D1-4634-80E1-74EFEB10F2BFQ51380197-1DCB6F34-0AE8-4FFE-8C1D-96C0F0B54F1BQ51490006-AB5B6151-4C27-480A-BB1C-156A486E9DA4Q51585179-EC4ED243-76C3-4D8A-A7A0-3C9BC246E63EQ51597756-971865B8-3B8F-482D-972E-B6FE6C6B3456Q52577306-E9CB9341-8CAD-4ABA-B55E-E99C42A1F05AQ53237243-559B9E1F-FE78-415C-9974-1EB3780941D3Q53850007-D1761326-B0C6-42D6-B341-A1ABE7F949EFQ55232113-814E1BB9-EEE7-4232-8944-6256EBAF8C3BQ58584488-CCCA7D47-D99E-4E74-9133-DB37397A1577Q58842177-E9EC5556-35D5-4D01-9139-21AA261B160A
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
S Frontoni
@ast
S Frontoni
@en
S Frontoni
@es
S Frontoni
@nl
type
label
S Frontoni
@ast
S Frontoni
@en
S Frontoni
@es
S Frontoni
@nl
prefLabel
S Frontoni
@ast
S Frontoni
@en
S Frontoni
@es
S Frontoni
@nl
P31
P496
0000-0001-8241-7552